Back to results
US 2017/0320833 A1Published application
Hepatitis c virus inhibitors
AssigneeBristol-Myers Squibb Company
InventorsMAKONEN BELEMA, Van N. Nguyen
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Claims2
A compound which is:
- or a pharmaceutically acceptable salt thereof.
A compound selected from:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.